Article
Sensitization of IL-2 signaling through TLR-7 enhances B lymphoma cell immunogenicity.
Journal of immunology (Baltimore, Md. : 1950) - 15 Mar 2006
Tomic Jelena, White Dionne, Shi Yonghong, Mena Jenny, Hammond Caitlin, He Liwei, Miller Richard L, Spaner David E
Abstract excerpt
The innate ability of B lymphoma cells to escape control by tumor-reactive T cells must be overcome to develop effective immunotherapies for these diseases. Because signals from both the innate and adaptive immune systems direct the acquisition of strong immunogenicity by professional APCs, the effects of IL-2 and the TLR-7 agonist, S28690, on the immunogenic properties of chronic lymphocytic leukemia (CLL) B...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
